This PR Sell Trigger?????
If checkpoint theory is revolutionary, and I do not doubt it, then:
1 - Why has not Eli Lilly bought out RGBP?
2 - If as RGBP's PR stated ("If our stuff pans out"); then what does Lilly know about NERF?
3 - With What Lilly does know, Why did they not make a major financial investment in Koos?
4 - Is Lilly's lack of RGBP investment interest telling this board that they have better candidates with better NERF's? Or does Lilly have it's own super secret NERF program?
IMO You could take a high risk flyer on RGBP, if their balance sheet justified it, track record justified it, and solid management. But, the reality is RGBP is insolvent and exists in Koosland = OTC Koosklomerate.
Bottom line, and indirect PR within same technology class is not investable.